SlateStone Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
SlateStone Wealth's AMGN Position: Q2 2026 in Review
SlateStone Wealth increased its Amgen (AMGN) stake by 3% in Q2 2026, buying an estimated $393K and bringing the position to 38,812 shares worth $14.1M. The position accounts for 1.08% of the portfolio, ranked #29.
SlateStone Wealth first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- SlateStone Wealth held 38,812 shares of Amgen worth $14.1M as of Q2 2026.
- SlateStone Wealth bought 1,147 Amgen shares in Q2 2026, an estimated $393K.
- Amgen made up 1.08% of SlateStone Wealth's portfolio in Q2 2026, its #29 holding.
- SlateStone Wealth first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.